MYRIAD
OUR
RESEARCH
  Myriad
     
 
   

Clinical Trials

This section contains current information about ongoing clinical development programs sponsored by Myriad Pharmaceuticals, Inc. For more detailed information, please see the specific drug sections as they become available.


Molecule Therapeutic Area Development Stage Status
FLURIZAN™ (Global) Alzheimer's Disease Phase 3 Fully Enrolled
FLURIZAN™ (US) Alzheimer's Disease Phase 3 Fully Enrolled
FLURIZAN™ (Open Label) Alzheimer's Disease Phase 3 Ongoing
Azixa™ (MPC-6827) Non-Small-Cell Lung Cancer Phase 2 Ongoing
Azixa™ (MPC-6827) Melanoma Phase 2 Ongoing
Azixa™ (MPC-6827) Glioblastoma Phase 2 Ongoing
Vivecon™ (MPC-9055) HIV/AIDS Phase 1 Ongoing
MPC-2130 Cancer Phase 1 Enrolling
MPC-0920 Thrombosis Phase 1 Completed

 


  
© 2008 Myriad Genetics, Inc.